|
⚲
|
| Highmount Everest Fund LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001340136 |
| Sale | 2003-09-01 |
| Fund | |
| Phone | 6462747470 |
| Address | 12 East 49th Street New York, 10017 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Berk Nowak | |
| Highmount Capital | |
| Darcy Garner Bhatia | |
| Steven Hoch | |
| Maarten van Hengel | |
| Brian Walsh |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
CRIA Inc
✚
|
0.0 | |
|
Crisp Charles R
✚
|
0.0 | |
|
CRISPR Therapeutics AG
✚
|
0.0 | |
|
Crist Peter D
✚
|
0.0 | |
|
6710 Equity LLC
✚
|
0.0 | |
|
Arborlight Inc.
✚
|
0.0 | |
|
Arbor Venture Emerging Markets Fund II, L.P.
✚
|
0.0 | |
|
Arbor Weymouth Investor LLC
✚
|
0.0 | |
|
ARCA biopharma, Inc.
✚
|
0.0 | |
|
Antares Venture Group LLC
✚
|
0.0 |